Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Focusing on short term investment goals can yield quick financial returns. Discover the right timing for your investment strategy.
27,474 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
A quiet, strategic move by Warren Buffett's Berkshire Hathaway placed a small bet on The New York Times. Here’s what ...
A major manager disclosed a sizable stake reduction in BXP, prompting questions about the outlook for Class A office ...
When a notable investor sells a stake in a popular dating platform, it can raise questions about the stock’s path for...
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Chevron has kept its promise to shareholders with steady cash returns. Discover how 16 quarters of returns totaling o...
This international recap dives into how June political headlines and tech softness have weighed on key markets. Learn...
Choosing a global stock core isn’t just about chasing returns. This guide compares State Street SPGM and iShares URTH...
Verizon fell today after a day of headline-driven moves, including strategic spin-offs and competitive shifts in the ...
A high-stakes portfolio shuffle by a famed activist investor grabbed headlines. This piece breaks down what happened,...
Redwire stock swung sharply during today’s session, leaving investors with questions about its business model and gro...
Nvidia sits at the center of AI, and May 20 earnings looms large. This guide breaks down whether you should Nvidia st...